UnknownPhase 1NCT05420519

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Studying Hereditary clear cell renal cell carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chongqing Precision Biotech Co., Ltd
Principal Investigator
Jianfeng Bi, M.D
The Second People's Hospital of Shandong Province
Intervention
CD70 CAR-T cells(biological)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
20212024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05420519 on ClinicalTrials.gov

Other trials for Hereditary clear cell renal cell carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary clear cell renal cell carcinoma

← Back to all trials